Sign in
CompletedNo phase

Aerobic vs Neuromuscular Exercise for Knee OA

Key facts

Who runs it
Frederiksberg University Hospital
Where
Denmark1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
150 people enrolled
Started
23 Feb 2024
Ended
12 Jun 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • eHIIT
  • NEMEX-e
Record updated
16 June 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (20)Hide the full registry criteria

Who can take part

  • Age ≥18- years
  • Diagnosis of tibiofemoral knee OA according to the American College of Rheumatology criteria
  • Radiographically confirmed diagnosis of tibiofemoral OA based on radiographs not older than 6 months
  • Average knee pain level ≥ 4 (0=No pain and 10=Worst pain) over the past week (7 days)
  • At least one of following risk factors for development of cardiovascular disease:; Body mass index ≥ 30 kg/m2; Hypertension (or in treatment of): Systolic ≥ 135 and/or diastolic ≥ 85 mm Hg; Elevated HbA1c (or in treatment of): ≥ 130.7 mg/dL (44 mmol/mol); Elevated Triglycerides (or in treatment of): ≥ 150 mg/dL (1.7 mmol/L); Elevated Cholesterol (or in treatment of) (Low density lipides, LDL): LDL ≥ 54 mg/dL (3.0 mmol/L)

Who cannot take part

  • Planned weight loss (non-pharmacological, pharmacological, and surgical) during study participation
  • Scheduled surgery during study participation
  • Treatment with biological medication
  • Known current cancer
  • Insulin dependent type 1 or type 2 diabetes
  • Psoriatic, rheumatoid, or gouty arthritis disease
  • Generalized pain syndromes such as fibromyalgia
  • Lumbar or cervical nerve root compression syndromes
  • Any other condition or impairment that, in the opinion of the investigator, makes a potential participant unsuitable for participation or which obstruct participation, such as a large knee joint effusion, uncontrolled diabetes/hypertension, psychiatric or cognitive disorders, language barriers, or opiate dependency
  • Contraindication to exercise (e.g., resting systolic blood pressure > 200 or diastolic blood pressure > 115, acute or reoccurring chest pain)
  • Unstable body weight the last 3 months (gain/loss outside +/- 5 kg)
  • Major cardiovascular event within the last 5 years
  • Impairments that prevent performance in high intensity aerobic exercise
  • Current or planned participation in other health research intervention studies
  • Pregnant/considering pregnancy

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The study aims to compare the effects of an education and High Intensity Interval Training program (eHIIT) with the widely used Neuromuscular Exercise and education program (NEMEX-e) on knee OA symptoms and risk factors for cardiovascular disease in people with knee OA and at least one risk factor for developement of cardiovascular disease. The main research questions the study aims to answer are:

Read full original descriptionShow less

* Is the eHIIT program better than the NEMEX-e program for reducing the risk of cardiovascular disease? * Are the two programs equally good at providing improvement in knee symptoms?

The 2 groups in the trial

  • Education and High Intensity Interval Training (eHIIT)Existing treatment, for comparison

    1 educational session lasting 1 hour. 12 weeks of supervised High Intensity Interval Training (HIIT) 3 times/week.

    Treatment: eHIIT

  • Neuromuscular exercise and education program (NEMEX-e)Existing treatment, for comparison

    2 educational sessions lasting 1 hour each. 8 weeks of supervised Neuromuscular Exercise 2 times/week.

    Treatment: NEMEX-e

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Comparative Effectiveness of High-intensity Aerobic Exercise and Biomechanical Neuromuscular Exercise for Treatment of Knee Osteoarthritis: A Randomised Open Label Trial
Record updated
16 June 2026